Immunocore develops biological product candidates based on its ImmTAX platform, from Oxfordshire, United Kingdom. It last closed at $27.81 on Nov 17, down 3.70% on the day. The average 12-month price target from 3 analysts is $57.33 (+106.2% from the last close), with a high of $80.00 and a low of $42.00. Analyst consensus is Buy, based on the latest ratings from 3 firms (2 buy, 1 hold, 0 sell).
Each firm's latest rating on IMCR in the past 90 days
Average 12-month target
$57.33
▲ 106.2% upside
Based on 3 analysts who set a price target on IMCR in the past 90 days. The average target is $57.33, with a high of $80.00 and a low of $42.00, compared with the last close of $27.81.
Low $42.00Avg $57.33High $80.00
Blue marker: last close $27.81
Highest target$80.00
Average target$57.33
Lowest target$42.00
Latest rating changes
Morgan StanleyMaintained
Nov 13Hold$42
HC Wainwright & Co.Maintained
Nov 10Buy$80
JP MorganReinstated
Aug 21Buy$50
MizuhoMaintained
Aug 3Hold$35
JefferiesDowngrade
Mar 16Hold$33
Date
Firm
Action
Rating
Price target
Nov 13
Morgan Stanley
Maintained
Hold
$42
Nov 10
HC Wainwright & Co.
Maintained
Buy
$80
Aug 21
JP Morgan
Reinstated
Buy
$50
Aug 3
Mizuho
Maintained
Hold
$35
Mar 16
Jefferies
Downgrade
Hold
$33
Loading…
Technical Analysis
IMCR · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 10% below its 20 day and 11% below its 50 day average. It is 13% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the swing low (Jun 11) at $27.59, and the nearest resistance the Pivot at $28.04.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 5.3%/day
Key levels
$40.7152 week high+46.4%
$32.66100 day average+17.4%
$31.54200 day average+13.4%
$30.7750 day average+10.6%
$30.7120 day average+10.4%
$29.54Swing high (Jun 12)+6.2%
$28.76Pivot R1+3.4%
$28.04Pivot+0.8%
$27.81Last close
$27.59Swing low (Jun 11)−0.8%
$27.3252 week low−1.8%
$27.09Pivot S1−2.6%
Indicators
RSI (14)
37.61
Weak, oversold below 30
Neutral
MACD
-0.42
Below its signal line
Bearish
Stochastic
21.8
Middle of its range
Neutral
ADX (14)
16.3
No clear trend
Williams %R
-90.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-187.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−7.4%
Change over 10 sessions
Bearish
ATR (14)
$1.46
Typical daily range, 5.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 10.3%/day
Key levels
$40.7152 week high+46.4%
$32.66100 day average+17.4%
$31.54200 day average+13.4%
$30.7750 day average+10.6%
$30.7120 day average+10.4%
$29.54Swing high (Jun 12)+6.2%
$28.76Pivot R1+3.4%
$28.04Pivot+0.8%
$27.81Last close
$27.59Swing low (Jun 11)−0.8%
$27.3252 week low−1.8%
$27.09Pivot S1−2.6%
Indicators
RSI (14)
37.01
Weak, oversold below 30
Neutral
MACD
-0.73
Below its signal line
Bearish
Stochastic
20.5
Middle of its range
Neutral
ADX (14)
15.3
No clear trend
Williams %R
-95.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-128.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.7%
Change over 10 sessions
Bearish
ATR (14)
$2.86
Typical daily range, 10.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for IMCR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IMCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow IMCR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How IMCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMCR is in one of them and how their past IMCR trades turned out.
Immunocore is a biological products company based in Oxfordshire, United Kingdom. It develops product candidates built on its ImmTAX platform, which it relies on as its core proprietary know-how. Its work involves collaborations with corporate partners, outside scientific collaborators and contract research organizations. Most of its product candidates are still in development and not yet sold to customers.